XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net income (loss) $ 8,273,478 $ (3,688,777)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Change in unrealized (gain) loss on open commodity futures contracts (7,140,769) 2,231,840
(Increase) decrease in dividends receivable 15,563 29,375
(Increase) decrease in interest receivable (3,819) (20,483)
(Increase) decrease in prepaid other 551 (794)
(Increase) decrease in prepaid insurance (9,698) (14,928)
(Increase) decrease in ETF transaction fees receivable 0 350
Increase (decrease) in General Partner management fees payable (2,617) (6,867)
Increase (decrease) in professional fees payable (78,419) (95,375)
Increase (decrease) in directors' fees payable 25 (329)
Increase (decrease) in license fees payable 1,907 0
Net cash provided by (used in) operating activities 1,056,202 (1,565,988)
Cash Flows from Financing Activities:    
Addition of partnership shares 0 11,820,219
Redemption of partnership shares (11,219,976) (12,242,667)
Net cash provided by (used in) financing activities (11,219,976) (422,448)
Net Increase (Decrease) in Cash and Cash Equivalents (10,163,774) (1,988,436)
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 68,932,943 90,074,519
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period $ 58,769,169 $ 88,086,083